BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pre-Clinical Outsourcing

Sartorius Introduces Genetically Engineered CHO Host Cell Line To Boost Biomanufacturing Productivity

New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold...

March 06, 2026 | News

AtomVie Supplies First Patient Dose In Radiopharm Theranostics Phase 1 2a Study Of 177Lu BetaBart

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first pat...

February 26, 2026 | News

Catalent And S Biomedics Partner To Advance Stem Cell Therapy For Parkinsons Disease

Catalent and S.Biomedics announced a strategic partnership to support the development and manufacturing of TED‑A9, S.Biomedics’ allogeneic pluripot...

February 23, 2026 | News

Bon Natural Life Establishes Joint Laboratory To Advance Bio Manufactured Natural Ingredients

Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, anno...

February 19, 2026 | News

GCCL And Medicover Integrated Clinical Services Sign MOU To Strengthen Multinational Trial Delivery

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an internation...

February 12, 2026 | News

AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...

February 12, 2026 | News

Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing

Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...

February 12, 2026 | News

WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...

February 04, 2026 | News

AstraZeneca Commits $15 Billion Investment To Expand R&D And Manufacturing Footprint In China Through 2030

Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China In...

February 03, 2026 | News

Merck Strengthens India As A Strategic Healthcare R&D Growth Engine With New Innovation Hub

A workplace designed for long-term growth, efficiency, and innovation Elevating Merck Healthcare’s R&D India Hub as a premier talent powerho...

February 02, 2026 | News

WuXi Biologics And HanchorBio Inc. Sign Strategic Collaboration To Advance Next Generation Fusion Biologics

WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a globa...

January 27, 2026 | News

Samsung Biologics Strengthens Long Term Growth Platform With Solid 2025 Financial Performance

Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent ...

January 22, 2026 | Company results

Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer

Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced the closing of a $70M Ser...

January 14, 2026 | News

Esco Aster Provides CMC Manufacturing Support For Shine On Biomedical HLA G Targeted Exosome Programme

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Bio...

January 07, 2026 | News

Stay Connected